DarioHealth to Report Fourth Quarter and Full Year 2021 Results on Monday, March 21
DarioHealth Corp. (Nasdaq: DRIO) will release its financial results for the fourth quarter and full year ended December 31, 2021, on March 21, 2022, post-market close. A conference call will be held on March 22, 2022, at 8:30 am EDT, featuring CEO Erez Raphael and other executives. Participants should join 10 minutes early, with a replay available until April 22, 2022. DarioHealth focuses on digital therapeutics to manage chronic conditions through AI-powered tools and personalized experiences.
- None.
- None.
NEW YORK, March 14, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and full year ended December 31, 2021 on Monday, March 21, 2022, after the close of trading. The company will host a conference call and webcast on Tuesday, March 22, at 8:30 am Eastern Time.
Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer will host the call.
Conference Call Details
Date: Tuesday, March 22, 8:30am EDT
Dial-in Number: 877-451-6152
International Dial-in: 201-389-0879
Conference ID: 13727795
Conference title: DarioHealth Fourth Quarter 2021 Results Call
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1535684&tp_key=fbf3737388
Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through April 22, 2022. To listen to the replay, dial 844-512-2921 (domestic) or 412-317-6671 (international) and use replay passcode 13727795.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform.
Dario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes.
Dario's unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results.
The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and utilizes a performance-based approach to improve its users' health.
On the path to better health, Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions or for more information, visit http://dariohealth.com.
DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220
Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390
Media Contact:
Josephine Galatioto
Josephine.galatioto@russopartnersllc.com
+1-212-845-4262
View original content:https://www.prnewswire.com/news-releases/dariohealth-to-report-fourth-quarter-and-full-year-2021-results-on-monday-march-21-301501734.html
SOURCE DarioHealth Corp.
FAQ
When will DarioHealth Corp. (DRIO) report its fourth quarter 2021 results?
What time is the DarioHealth conference call for the fourth quarter results?
Who will host the DarioHealth conference call?
How can I access the DarioHealth conference call?
Until when will the DarioHealth conference call replay be available?
